|
Bladder Cancer Detection Resource Center - References |
|
|
|
|
|
|
|
|
|
Bladder Cancer Diagnosis and Monitoring Center
Clinical References
Complete User Guide
AUA MA 2009 - Preoperative prediction of invasive upper-tract urothelial carcinoma stage using hydronephrosis, ureteroscopic biopsy grade, and urinary cytology - Session Highlights
Tuesday, 13 October 2009
AUA MA 2009 - Diagnostic accuracy of urinary cytology for upper-tract urothelial carcinoma (UTUC) - Session Highlights
Tuesday, 13 October 2009
The value of urinary cytology in the diagnostic of high grade urothelial tumors - Abstract
Tuesday, 08 September 2009
Beyond the Abstract - The current role of telomerase in the diagnosis of bladder cancer, by Sara Bravaccini, MD
Wednesday, 02 September 2009
Early assessment for bladder cancer could improve early detection rates for women
Friday, 28 August 2009
Meta-analysis of fluorescence in situ hybridization and cytology for diagnosis of bladder cancer - Abstract
Friday, 21 August 2009
Maratona Urológica 2009 - Pathology of Bladder Cancer - Session Highlights
Tuesday, 18 August 2009
Expression and clinical significance of nuclear matrix protein 22 and cytokeratin 18 in transitional cell carcinoma of the bladder - Abstract
Thursday, 06 August 2009
Urine-Based Tumour Diagnostics for Bladder Cancer : Effects of the New Histopathological Classification - Food for Thought - Abstract
Monday, 20 July 2009
Detection of Urothelial Bladder Cancer Cells in Voided Urine Can Be Improved by a Combination of Cytology and Standardized Microsatellite Analysis - Abstract
Tuesday, 16 June 2009
Bladder Cancer Screening in a High Risk Asymptomatic Population Using a Point of Care Urine Based Protein Tumor Marker
Thursday, 11 June 2009
Summaries of Clinical Studies Relating to Veterans and Bladder Cancer
Monday, 01 June 2009
Veterans Health Administration Office of Patient Care Services Technology Assessment Program
Monday, 01 June 2009
AUA 2009 - Bladder Cancer: Superficial - NMP22 is Predictive of Recurrence in High Risk Superficial Bladder Cancer Patients - Session Highlights
Wednesday, 29 April 2009
AUA 2009 - NMP22 is Predictive of Recurrence in High-Risk Superficial Bladder Cancer Patients - Session Highlights
Wednesday, 29 April 2009
AUA 2009 - NMP22 is Predictive of Recurrence in High Risk Superficial Bladder Cancer Patients - Poster
Tuesday, 28 April 2009
Impact of Clinical Factors, Including a Point-of-care Nuclear Matrix Protein-22 Assay and Cytology, on Bladder Cancer Detection - Abstract
Monday, 13 April 2009
Combining the NMP22 Bladderchek Urine Test with Cystoscopy Can Detect Bladder Cancer in its Early Stages, with 99 Percent Detection Rates
Wednesday, 08 April 2009
Influence of Blood Cells in Urine Samples on Results of Screening for Urothelial Carcinoma with NMP22 Bladder Chek - Abstract
Friday, 03 April 2009
Influence of Blood Cells in Urine Samples on Results of Screening for Urothelial Carcinoma with NMP22 Bladder Chek
Wednesday, 04 February 2009
UIJ - A Cost Comparison of the Diagnostic Modalities Used in the Detection of Urothelial Carcinoma in Patients Undergoing Evaluation for Hematuria
Friday, 03 April 2009
Nuclear Matrix Protein 22 as Adjunct to Urine Cytology and Cystoscopy in Follow-up of Superficial TCC of Urinary Bladder
Friday, 30 January 2009
Urine Concentration of Nuclear Matrix Protein 22 for Diagnosis of Transitional Cell Carcinoma of Bladder
Friday, 23 January 2009
UIJ - Utilization of the NMP22® BladderChek® Urine Test as an Adjunct to Atypical Cytology in the Detection of Bladder Cancer Recurrence
Wednesday, 21 January 2009
Detection of Tumours of the Urinary Tract in Voided Urine
Monday, 15 December 2008
A Cost Comparison of the Diagnostic Modalities Used in the Detection of Urothelial Carcinoma in Patients Undergoing Evaluation for Hematuria
Monday, 01 December 2008
Utilization of the NMP22® BladderChek® Urine Test as an Adjunct to Atypical Cytology in the Detection of Bladder Cancer Recurrence
Thursday, 23 October 2008
Screening for Bladder Cancer Using Urine-Based Tumor Markers
Tuesday, 21 October 2008
Focus on Urinary Bladder Cancer Markers: A Review
Tuesday, 21 October 2008
The Clinical Utility of Atypical Cytology is Significantly Increased in Both Screening and Monitoring for Bladder Cancer When Indexed with Nuclear Matrix Protein-22
Wednesday, 20 August 2008
 Powerpoint with Audio - Interview on Clinical Practice Experience with NMP22
Friday, August 15 2008
Biomarkers for Detection and Surveillance of Bladder Cancer - Abstract
Wednesday, 13 August 2008
ASCO 2008 Annual Meeting - Description and Early Results of a Newly Established Bladder Cancer Screening Program in a High Risk Population
Wednesday, 13 August 2008
ASCO 2008 Annual Meeting - Significance of Urine NMP22 in the Screening of Urothelial Cancer
Friday, 08 August 2008
Could Nuclear Matrix Protein 22 (NMP22) Play a Role with Urine Cytology in Screening for Bladder Cancer? - Experience at Kuwait University - Abstract
Monday, 21 July 2008
 Podcast - "Ask the Expert" - We Tried NMP22 Five Years Ago when it First Came Out and after Receiving False Negatives, We Elected to not Continue its Use. Do you have Confidence in the Sensitivity of the Test?
Thursday, 17 July 2008
Podcast - "Ask the Expert" - I am Getting a Positive NMP22 result but a Negative Cystoscopy. What does it Mean?
Thursday, 17 July 2008
Podcast - "Ask the Expert" - Do You have an Opinion as to when the NMP22 Test Should be Run?
Thursday, 17 July 2008
Podcast - "Ask the Expert" - Should the NMP22 Test be Taken Prior to Cystoscopy or at the Same Patient Visit?
Thursday, 17 July 2008
Impact of Risk Factors on the Performance of the Nuclear Matrix Protein 22 Point-of-Care Test for Bladder Cancer Detection
Monday, 23 June 2008
AUA 2008 - Evaluation of Urinary Nuclear Matrix Protein 22 Test for Detection of Upper Tract Urothelial Carcinoma
Sunday, 18 May 2008
AUA 2008 - Evaluation of Urinary Nuclear Matrix Protein 22 Test for Detection of Upper Tract Urothelial Carcinoma - Podcast
Sunday, 18 May 2008
AUA 2008 - Evaluation of Urinary Nuclear Matrix Protein 22 Test for Detection of Upper Tract Urothelial Carcinoma - Download Powerpoint Slides
Sunday, 18 May 2008
AUA 2008: Retired Firefighters Could be at Increased Risk for Developing Bladder Cancer
Friday, 16 May 2008
Legislation Would Make Cancer Screenings Available to All RI Firefighters
Monday, 24 March 2008
Guidelines for Development of Diagnostic Markers in Bladder Cancer
Friday, 14 March 2008
BJUI Mini Reviews - Pathological Variants of Invasive Bladder Cancer According to Their Suggested Clinical Significance
Monday, 3 March 2008
Nomograms for Bladder Cancer
Monday, 18 February 2008
Economic Impact of Tumor Markers in Bladder Cancer Surveillance
Friday, 07 March 2008
AUA NY Section 2007 - Multimedia Presentations: State-of-the-Art Update on Bladder Cancer
Tuesday, 05 February 2008
WUF 2008 Presentations - Optimizing Outcomes at Every Stage of Bladder Cancer: Do We Practice It?
Friday, 01 February 2008
Long-Term Outcome of Home Dipstick Testing for Hematuria
Wednesday, 16 January 2008
Florida Bladder Cancer Trends 1981 to 2004: Minimal Progress in Decreasing Advanced Disease -Review
Thursday, 03 January 2008
Role of Urinary Cathepsin B and L in the Detection of Bladder Urothelial Cell Carcinoma
Thursday, 20 December 2007
SUO 2007 - Impact of Clinical Factors Including a Point-of-Care Assay and Cytology on Risk of Bladder Cancer
Monday, 10 December 2007
SUO 2007 - Efficacy of Nuclear Matrix Protien 22 Asay for Detection of Upper Tract Urothelial Carcinoma
Monday, 10 December 2007
SUO 2007 - Late Breaking Developments: Transitional Cell Carcinoma
Monday, 03 December 2007
SUO 2007 - Bladder Cancer I: Non-muscle Invasive Bladder Cancer - AUA Guidelines
Monday, 03 December 2007
SUO 2007 - Bladder Cancer I: Non-muscle Invasive Bladder Cancer - SIU Guidelines
Monday, 03 December 2007
SUO 2007 - Bladder Cancer I: Non-muscle Invasive Bladder Cancer - EAU Guidelines
Monday, 03 December 2007
Bladder Health Week 2007 - Urine Based Tumor Markers for Bladder Cancer Screening: An Update
Wednesday, 7 November 2007
Bladder Health Week 2007 - Screening for Bladder Cancer
Wednesday, 7 November 2007
SIU 2007 MP [04.08] - Clinical Evaluation of NMP22 in the Diagnosis of Urothelial Cancer
Monday, 3 September 2007
SIU 2007 MP [04.11] - Non-Invasive Detection of Bladder Cancer by Measurement of Tumorrelated Transcript Markers in Urine
Monday, 3 September 2007
Stopping Smoking might Reduce Tumor Recurrence in Non-Muscle Invasive Bladder Cancer
Wednesday, 1 August 2007
Improving Bladder Cancer Detection: The Value of Combining A Molecular Test with Cystoscopy
Supplement to Contemporary Urology, September, 2006
Diagnosis of Bladder Cancer Using a Point-of-Care Proteomic Assay (NMP22 BladderChek): A Multi Center Study
Supplement to Contemporary Urology, August 2005
AUA 2007 - Review of Bladder Cancer: Detection and Screening
Tuesday, 29 May 2007
Leading Urologists Present Studies at the American Urological Association Supporting Use of the NMP22® BladderChek® Test for Diagnosing and Managing Bladder Cancer
Friday, 25 May 2007
AUA 2007 - Impact of Risk Factors on the Performance of a Point-of-Care Bladder Cancer Test - Poster
Monday, 21 May 2007
AUA 2007 - NMP22 as an Adjunct to Urine Cytology and Cystoscopy in the Follow Up of Superficial TCC of Urinary Bladder - Poster
Monday, 21 May 2007
AUA 2007 ABST[1083] Impact of Risk Factors on the Performance of a Point-of-Care Bladder Cancer Test
Monday, 21 May 2007
AUA 2007 - Review of Bladder Cancer: Detection and Screening
Monday, 21 May 2007
Matritech’s NMP22® BladderChek® Test will be Featured in Presentations at the American Urological Association (AUA) Annual Meeting
Monday, 14 May 2007
AUA 2007 ABST[1098] NMP22 as an Adjunct to Urine Cytology and Cystoscopy in Follow-Up of Superficial TCC of the Urinary Bladder
Tuesday, 01 May 2007
San Francisco Firefighters Cancer Prevention Foundation Spearheads Campaign Calling for Action to Address Firefighters Increased Risk for Cancer - Bladder Cancer Screening is the First Program Underway
Wednesday, 25 April 2007
Matritech's NMP22(R) BladderChek(R) Test Being Used in Screening
Wednesday, 25 April 2007
Improved Detection and Surveillance of Bladder Cancer Using a Point-of-Care NMP22 Assay
Monday, 12 March 2007
RECAP FROM SE AUA PRESENTATION BY GIORA KATZ, MD
Thursday, 01 March 2007
European Urology - Validation of the Diagnostic Value of NMP22® BladderChek® Test as a Marker for Bladder Cancer by Photodynamic Diagnosis
Friday, 02 February 2007
Clinical Model of Lifetime Cost of Treating Bladder Cancer and Associated Complications
Friday, 06 October 2006
The Role for Screening High Risk Patients for Bladder Cancer
Thursday, 07 September 2006
AUA 2006 - An Update On Bladder Cancer Detection and Screening
Tuesday, 23 May 2006
AUA 2006 - ABST [1238] Evaluation Of Risk For Muscle Invasive And High Grade Bladder Cancer Using A Point-Of-Care Assay
Sunday, 21 May 2006
AUA 2006 - ABST [984] VARIABILITY IN THE PERFORMANCE OF NUCLEAR MATRIX PROTEIN 22 IN THE DETECTION OF BLADDER CANCER
Sunday, 21 May 2006
AUA 2006 - ABST [891] SURVEILLANCE OF PATIENTS WITH A HISTORY OF BLADDER CANCER USING A POINT-OF-CARE PROTEOMIC ASSAY
Sunday, 21 May 2006
AUA 2006 - Screening High Risk Patients For Bladder Cancer Is Cost-Effective
Saturday, 20 May 2006
Apoptosis Receptor Holds Potential As Urinary Marker For Bladder Cancer
Friday, 05 May 2006
Wisconsin Urologist Reports Wisconsin Industrial Workers Might Be At Increased Risk For Bladder Cancer
Thursday, 04 May 2006
Initial Diagnosis Of Bladder Cancer Using A Point-Of-Care Assay
Thursday, 06 April 2006
Study Assesses NMP22 in Combination With Cystoscopy To Detect Recurrent Bladder Tumors
Friday, 17 February 2006
Role Of Voided Urine NMP22 Point-Of-Care Assay Clarified For Bladder Cancer Surveillance
Monday, 23 January 2006
Study In The Journal of American Medical Association (JAMA) Reports Significant Improvement In Bladder Cancer Detection ? 99% Of Malignancies Found
Wednesday, 18 January 2006
Urine Test Helps Detect Recurrent Bladder Cancer
Wednesday, 18 January 2006
Bladder Cancer Support Groups And Community Outreach
Thursday, 15 December 2005
Health Briefs for Everyone / Bladder Cancer: New Tool for Early Detection
Friday, 11 November 2005
Bladder Cancer Awareness? Early Detection Saves Lives
Friday, 11 November 2005
EAU 2005 - ABST[628] VOIDED URINARY SPECIMEN-COMPARISON OF A MULTITARGET IN SITU HYBRIDISATION FLUORESCENCE (FISH) ASSAY, NMP22-BLADDERCHEK© AND CONVENTIONAL CYTOLOGY FOR DETECTION OF TRANSITIONAL CELL CANCER OF THE BLADDER
Thursday, 09 June 2005
EAU 2005 - ABST[630] THE NEW PROTEOMIC-BASED POINT-OF-CARE (POC) URINE NMP22-BLADDER.CHEK® COMPARED TO THE STANDARD NMP22-ELISA URINE LAB TEST FOR BLADDER CANCER DETECTION
Thursday, 09 June 2005
EAU 2005 - ABST[635] CK 20 MRNA EXPRESSION IN URINE PREDICTS TUMOUR RECURRENCE IN SUPERFICIAL TRANSITIONAL CELL CARCINOMA
Thursday, 09 June 2005
Bladder Cancer: Detection and Screening - 2005-05-23
Monday, 23 May 2005
Bladder Cancer - Part 5
Monday, 23 May 2005
AUA Scientific News Brief - Bladder Cancer Clinical Findings
Monday, 23 May 2005
Detection of Bladder Cancer Using A Point-of-care Proteomic Assay
Monday, 28 February 2005
SIU 2004 Conferences - Moderated Poster 18
Friday, 15 October 2004
Urinary Survivin Helpful in Bladder Cancer Diagnosis
Friday, 12 March 2004
AUA 2003 Selected Abstracts — Bladder Cancer Part II
Tuesday, 29 April 2003
AUA 2003 Selected Abstracts — Voiding Dysfunction
Tuesday, 29 April 2003
Bladder Cancer
Monday, 28 April 2003
Please log-in or register in order to submit comments. Powered by AkoComment! |
Bladder Cancer 
